HSP can stimulate the innate immunity through binding to Toll-like receptors (TLRs) and also activate the adaptive immunity via cross-presentation of melanoma antigen peptides chaperoned by HSPs to specific CD8+ T cells. Here, HSP90B2P is linked to melanoma.